VYNE Therapeutics Inc (VYNE)
2.57
+0.25
(+10.78%)
USD |
NASDAQ |
Apr 24, 16:00
2.69
+0.12
(+4.67%)
Pre-Market: 08:48
VYNE Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.4456 |
| March 31, 2021 | 0.3582 |
| December 31, 2020 | 0.8848 |
| September 30, 2020 | 0.6668 |
| June 30, 2020 | 0.4602 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.472 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.8848
Maximum
Dec 2020
0.173
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 97.68M |
| Total Liabilities (Quarterly) | 8.95M |
| Shareholders Equity (Quarterly) | 88.74M |
| Current Ratio | 12.73 |